Patent US4753873A successfully refreshed from Google Patents.
US4753873A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Peptides for the diagnosis of HTLV-III antibodies, their preparation and use
Assignee: Cambridge Biotech Corp
•
Filing: 1986-02-03
•
Granted: 1988-06-28
•
Expires: 2006-02-03
Abstract
Abstract Certain peptide fragments of the human T-cell leukemia (lymphotropic) virus (HTLV-III) are particularly immunoreactive to HTLV-III antibodies, and can therefore be applied to immunodiagnostic tests for the detection of antibodies to HTLV-III.
Inventors
- 👤 Gerald A. Beltz
- 👤 Richard M. Thorn
- 👤 Dante J. Marciani
- 👤 Chung-Ho Hung
- 👤 William A. Haseltine
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 02:30
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/005; C07K1/00; C07K1/107; C07K1/113; C07K1/1133; C07K1/1136; C07K16/00; C07K16/08; C07K16/10; C07K16/112; C07K16/114; A; A61; A61K; A61K38/00; C12; C12N; C12N2740/00; C12N2740/00011; C12N2740/10011; C12N2740/14011; C12N2740/14022; C12N2740/16011; C12N2740/16111; C12N2740/16122; Y; Y10; Y10S; Y10S435/00; Y10S435/81; Y10S435/974; Y10S435/975; Y10S436/00; Y10S436/807; Y10S436/808; Y10S436/811; Y10S930/00; Y10S930/01; Y10S930/22; Y10S930/221; Y10S930/30
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
45 words
A peptide fragment which is immunoreactive to antibodies against the HTLV-III virus and is encoded by a nucleotide sequence of the HTLV-III provirus as shown in FIG. 19 from about 7199 to about 7349, about 7419 to about 7850, and about 7917 to about 8052.
Claim 2
Dependent Claim
45 words
A peptide fragment which is immunoreactive to antibodies against the HTLV-III virus and is encoded by a nucleotide sequence of the HTLV-III provirus as shown in FIG. 19 from about 7199 to about 7349, about 7419 to about 7850, and about 7917 to about 8052.
Claim 3
Dependent Claim
42 words
A peptide fragment which is immunoreactive to antibodies against the HTLV-III provirus and encoded by a nucleotide sequence as shown in FIGS. 18 and 19 from about 6827 to about 7349, about 7419 to about 7850, and about 7917 to about 8052.
Claim 4
Dependent Claim
42 words
A peptide fragment which is immunoreactive to antibodies against the HTLV-III provirus and encoded by a nucleotide sequence as shown in FIGS. 18 and 19 from about 6827 to about 7349, about 7419 to about 7850, and about 7917 to about 8052.
Claim 5
Dependent Claim
45 words
A peptide fragment which is immunoreactive to antibodies against the HTLV-III virus and is encoded by a nucleotide sequence as shown in FIG. 21 of the HTLV-III provirus from about 6827 to about 6936, about 6952 to about 7349, and about 7419 to about 7802.
Claim 6
Dependent Claim
45 words
A peptide fragment which is immunoreactive to antibodies against the HTLV-III virus and is encoded by a nucleotide sequence as shown in FIG. 21 of the HTLV-III provirus from about 6827 to about 6936, about 6952 to about 7349, and about 7419 to about 7802.
Claim 7
Dependent Claim
15 words
An antibody raised against a peptide fragment as claimed in any one of claims 1-3.
Claim 8
Dependent Claim
9 words
The antibody of claim 4 comprising a monoclonal antibody.
Claim 9
Independent Claim
40 words
A method for the detection of antibodies against the HTLV-III virus comprising contacting a peptide fragment of any one of claims 1-3 with a sample suspected of containing antibodies against the HTLV-III virus and detecting the presence of said antibodies.
Claim 10
Dependent Claim
37 words
A method for the detection of HTLV-III virus or portions thereof comprising contacting a sample suspected of containing the HTLV-III virus or portions thereof with an antibody of claim 4 and detecting the presence of said virus.
Claim 11
Dependent Claim
47 words
The method of claim 6 comprising immobilizing said peptide fragment on a solid particles selected from the group consisting of latex, gelatin, red blood cells, nylon, liposomes, and gold particles and detecting the presence of said HTLV-III antibodies by the agglutination of said antibodies with said fragment.
Claim 12
Dependent Claim
45 words
The method of claim 6 comprising immobilizing said peptide fragment on a solid phase immunoabsorbent and detecting the presence of said HTLV-III antibodies with a detectably labeled antibody which is specific for said peptide fragment or with a detectably labeled anti-antibody to said HTLV-III antibodies.
Claim 13
Dependent Claim
77 words
The method of claim 9 wherein said detectably labeled antibody or said detectably labeled anti-antibody is enzyme-labeled and further comprising incubating said peptide fragment immobilized on said solid phase with said sample and with said enzyme-labeled antibody or said enzyme-labeled anti-antibody to allow the components to react; washing to remove unreacted material from said solid phase; and applying to said solid phase an indicator capable of reacting with said enzyme label to produce a detectable enzyme-substrate reaction.
Claim 14
Dependent Claim
47 words
The method of claim 7 further comprising a first antibody specific against said HTLV-III virus or portions thereof immobilized on a solid phase immuno-absorbent and a detectably labeled second antibody specific against said HTLV-III virus or portions thereof or a detectably labeled anti-antibody to said first antibody.
Claim 15
Dependent Claim
77 words
The method of claim 11 wherein said detectably labeled antibody or said detectably labeled anti-antibody is enzyme-labeled and further comprising incubating said first antibody immobilized on said solid phase with said sample and with said enzyme-labeled antibody or said enzyme-labeled anti-antibody to allow the components to react; washing to remove unreacted material from said solid phase; and applying to said solid phase an indicator capable of reacting with said enzyme label to produce a detectable enzyme-substrate reaction.
Claim 16
Dependent Claim
26 words
The method of claim 9 wherein said detectable label is selected from the group consisting of radioactive isotope labels, fluorescent labels, chemiluminescent labels, and bioluminescent labels.
Claim 17
Dependent Claim
26 words
The method of claim 11 wherein said detectable label is selected from the group consisting of radioactive isotope labels, fluorescent labels, chemiluminescent labels and bioluminescent labels.
Claim 18
Dependent Claim
59 words
A kit for detecting HTLV-III antibodies in a sample comprising a carrier being compartmentalized to receive one or more container means in close confinement therein, a first container means comprising a peptide fragment according to any one of claims 1-3 immobilized on an solid phase immunoabsorbent and a second container means containing a detectably labeled anti-antibody to HTLV-III antibodies.
Claim 19
Dependent Claim
86 words
A kit for detecting the HTLV-III virus or portions thereof in a sample comprising a carrier being compartmentalized to receive one or more container means in close confinement therein, a first container means containing a first antibody according to claim 4 immobilized on a solid phase immunoabsorbent and second container means comprising a detectably labeled second antibody according to claim 33 which is cross-reactive with a different domain of the HTLV-III virus from said first antibody or having a detectably labeled anti-antibody to said first antibody.
Claim 20
Dependent Claim
29 words
The kit according to claim 15 wherein said kit containing only a first container means comprising said immobilized fragment and wherein the HTLV-III antibodies in said sample causes agglutination.
References Cited (Backward Citations)
US4595654A
Cited
US4520113A
Cited
US4652599A
Cited
WO1986001827A1
Cited
WO1986001834A1
Cited
EP0185444A2
Cited
WO1986002930A1
Cited
EP0187041B1
Cited
WO1986004611A1
Cited
WO1986004613A1
Cited
US4629783A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-06-28 | 1991-12-28 | 1992-06-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-06-28 | 1995-12-28 | 1996-06-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-06-28 | 1999-12-28 | 2000-06-28 | $7700.00 | Window Closed / Lapsed |